Large-Cap Segment Sees Mixed Performance Amid Defensive and Cyclical Divergence

1 hour ago
share
Share Via
The large-cap segment experienced a mixed session with the BSE 100 index declining by 0.3% on 28 Apr 2026, extending a five-day slide of 1.36%. While heavyweight stocks such as ONGC delivered modest gains, defensive names like Sun Pharma Industries showed signs of renewed optimism, reflecting a nuanced market environment where cyclical and defensive sectors diverge in performance.

Index Performance and Market Breadth

The large-cap index, represented by the BSE 100, has been under pressure over the past week, shedding 1.36% amid cautious investor sentiment. On the day in focus, the index declined by 0.3%, with 40 stocks advancing against 60 decliners, resulting in an advance-decline ratio of 0.67x. This breadth indicates a cautious market mood, with more stocks falling than rising, signalling selective buying rather than broad-based strength.

Top Movers: ONGC Leads Gains While Eternal Lags

Among the large-cap constituents, ONGC emerged as the best performer, delivering a return of 4.36%. The energy heavyweight’s gains were supported by stable crude oil prices and positive sectoral momentum. Conversely, Eternal was the worst performer in the segment, declining by 3.38%, reflecting sector-specific headwinds and profit-taking pressures.

Technical Upgrades Signal Shifts in Sentiment

Technical calls within the large-cap universe have seen notable upgrades recently. Axis Bank and Lupin have been upgraded from mildly bullish to bullish, indicating strengthening momentum. Similarly, Sun Pharma Industries has moved from a sideways trend to mildly bullish, suggesting improving investor confidence in the pharmaceutical sector. Samvardhana Motherson and SBI also received upgrades to mildly bullish, reflecting positive technical signals in the auto components and banking sectors respectively.

Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!

  • - Hidden turnaround gem
  • - Solid fundamentals confirmed
  • - Large Cap opportunity

Discover This Hidden Gem →

Defensive Versus Cyclical Trends

The large-cap segment continues to reflect a divergence between defensive and cyclical stocks. Defensive sectors such as pharmaceuticals, represented by Sun Pharma Industries, are gaining traction as investors seek stability amid broader market volatility. The recent upgrade of Sun Pharma’s technical call to mildly bullish underscores this trend, supported by steady fundamentals and resilient earnings outlook.

On the other hand, cyclical sectors like energy and banking show mixed signals. While ONGC’s 4.36% return highlights strength in the energy space, the broader banking sector remains cautiously optimistic with Axis Bank and SBI receiving technical upgrades but overall market pressure limiting gains. This cautious stance is likely due to macroeconomic uncertainties and upcoming earnings announcements.

Upcoming Earnings to Influence Market Direction

Investor focus is shifting towards key earnings announcements scheduled in the coming days, which could provide fresh impetus or headwinds for the large-cap segment. Notable results expected include Federal Bank, Vedanta, Bajaj Finance, and Adani Power on 29 Apr 2026, followed by Indus Towers on 30 Apr 2026. These results will be closely analysed for guidance on sectoral trends and corporate earnings momentum.

Sun Pharma Industries: From Hold to Buy

Sun Pharma Industries has recently been upgraded from a Hold to a Buy rating, reflecting improved fundamentals and positive technical momentum. This upgrade aligns with the broader defensive sector’s appeal in the current market environment. Investors are advised to monitor the stock closely as it could offer a stable investment avenue amid ongoing market fluctuations.

Sectoral Outlook and Market Implications

The large-cap segment’s recent performance highlights the ongoing tussle between defensive resilience and cyclical recovery. While defensive stocks provide a cushion against volatility, cyclical names like ONGC and select banking stocks offer upside potential if macroeconomic conditions improve. The mixed advance-decline ratio and technical upgrades suggest a market in search of direction, with selective stock picking likely to be the preferred strategy for investors.

Curious about from ? Get the complete picture with our detailed research report covering fundamentals, technicals, peer analysis, and everything you need to decide!

  • - Detailed research coverage
  • - Technical + fundamental view
  • - Decision-ready insights

Get the Complete Analysis →

Investor Takeaway

For investors navigating the large-cap space, the current environment calls for a balanced approach. Defensive stocks like Sun Pharma Industries offer stability and have been upgraded to Buy, signalling confidence in their earnings durability. Meanwhile, cyclical stocks such as ONGC and select banking names present opportunities for gains, albeit with heightened risk due to macroeconomic uncertainties.

Market participants should also keep a close watch on the upcoming earnings season, which could act as a catalyst for renewed momentum or increased volatility. Technical upgrades in several large-cap stocks suggest pockets of strength that can be leveraged through selective exposure.

Overall, the large-cap segment remains a battleground between defensive resilience and cyclical recovery, with the index’s recent decline underscoring the need for careful stock selection and risk management.

Mojo Stocks - The Top 1% Picks across Markets

Top 10 Large Cap Mid Cap Small Cap
{{col.header}}
Latest
OPEN CALL
CLOSED CALL
{{s[col.key]}} {{s.change_value}}
{{ s.score.value }} - {{ s.score.call_type }}
{{ s.dot_summary.score }} - {{ s.dot_summary.scoreText }}
{{s[col.key]}} {{col.extra}}

Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News